BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33421629)

  • 1. Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons.
    Hagström H; Thiele M; Sharma R; Simon TG; Roelstraete B; Söderling J; Ludvigsson JF
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):918-929.e8. PubMed ID: 33421629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease.
    Hagström H; Thiele M; Sharma R; Simon TG; Roelstraete B; Söderling J; Sundström J; Ludvigsson JF
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1841-1853.e12. PubMed ID: 36332805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.
    Hagström H; Thiele M; Simon TG; Sharma R; Röckert Tjernberg A; Roelstraete B; Söderling J; Ludvigsson JF
    United European Gastroenterol J; 2022 Mar; 10(2):198-211. PubMed ID: 35088575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients.
    Hagström H; Thiele M; Roelstraete B; Söderling J; Ludvigsson JF
    Gut; 2021 Jan; 70(1):170-179. PubMed ID: 32220902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.
    Kim W; Jeong D; Chung J; Lee D; Joo S; Jang ES; Choi YJ; Yoon H; Shin CM; Park YS; Jeong SH; Kim N; Lee DH; Kim JW
    Sci Rep; 2019 Mar; 9(1):3236. PubMed ID: 30824851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
    Ioannou GN; Green P; Kerr KF; Berry K
    J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.
    Bengtsson B; Widman L; Wahlin S; Stål P; Björkström NK; Hagström H
    United European Gastroenterol J; 2022 Jun; 10(5):465-476. PubMed ID: 35491484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol use and hepatocellular carcinoma risk in patients with alcohol-related cirrhosis.
    Kraglund F; Birn-Rydder R; Sørensen MD; Abazi R; Villadsen GE; Jepsen P
    Scand J Gastroenterol; 2023; 58(11):1321-1327. PubMed ID: 37288811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of previous HBV infection on hepatocellular carcinoma with alcoholic liver disease].
    Tokushige K; Hashimoto E; Tobari M; Yatsuji S; Takakura M; Taniai M; Shiratori K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Apr; 41(2):120-7. PubMed ID: 16734279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Features and Outcomes of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Disease: A US Multicenter Study.
    deLemos A; Patel M; Gawrieh S; Burney H; Dakhoul L; Miller E; Scanga A; Kettler C; Liu H; Roche P; Wattacheril J; Chalasani N
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00139. PubMed ID: 32352723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.
    Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagström H
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1048-1057.e2. PubMed ID: 38237695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
    Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
    Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in the setting of alcohol-related liver disease.
    Ganne-Carrié N; Nahon P
    J Hepatol; 2019 Feb; 70(2):284-293. PubMed ID: 30658729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease.
    Kodama K; Tokushige K; Hashimoto E; Taniai M; Shiratori K
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E247-52. PubMed ID: 23320802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.